agmatine has been researched along with Body Weight in 12 studies
Agmatine: Decarboxylated arginine, isolated from several plant and animal sources, e.g., pollen, ergot, herring sperm, octopus muscle.
Body Weight: The mass or quantity of heaviness of an individual. It is expressed by units of pounds or kilograms.
| Excerpt | Relevance | Reference |
|---|---|---|
| "The present study investigated the pharmacological effect of agmatine in Complete Freud Adjuvant (CFA) induced arthritis and cachexia in rats." | 7.85 | Agmatine ameliorates adjuvant induced arthritis and inflammatory cachexia in rats. ( Chopde, CT; Gawande, DY; Kotagale, NR; Taksande, BG; Umekar, MJ, 2017) |
| "The present study investigated the pharmacological effect of agmatine in Complete Freud Adjuvant (CFA) induced arthritis and cachexia in rats." | 3.85 | Agmatine ameliorates adjuvant induced arthritis and inflammatory cachexia in rats. ( Chopde, CT; Gawande, DY; Kotagale, NR; Taksande, BG; Umekar, MJ, 2017) |
| "Agmatine treatment did not changed gelatinase activity within the plaque area." | 1.46 | Anti-Atherosclerotic Action of Agmatine in ApoE-Knockout Mice. ( Gajda, M; Gębska, A; Jawień, J; Korbut, R; Kuś, K; Olszanecki, R; Stachowicz, A; Suski, M; Totoń-Żurańska, J; Wiśniewska, A, 2017) |
| "Agmatine-treated rats showed slight, but significant reductions in body weight and blood pressure, and reduced water consumption during treatment, which recovered completely within 20 days after treatment cessation." | 1.39 | Evidence for oral agmatine sulfate safety--a 95-day high dosage pilot study with rats. ( Gilad, GM; Gilad, VH, 2013) |
| "Agmatine treatment also normalized the elevated corticosterone levels and prevented the body weight changes in chronically stressed animals." | 1.39 | Agmatine attenuates chronic unpredictable mild stress induced behavioral alteration in mice. ( Aglawe, MM; Dixit, MP; Faldu, DS; Kotagale, NR; Sakaria, JN; Taksande, BG; Umekar, MJ, 2013) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (8.33) | 18.2507 |
| 2000's | 3 (25.00) | 29.6817 |
| 2010's | 7 (58.33) | 24.3611 |
| 2020's | 1 (8.33) | 2.80 |
| Authors | Studies |
|---|---|
| Dixit, MP | 2 |
| Sammeta, SS | 1 |
| Dhokne, MD | 1 |
| Mangrulkar, S | 1 |
| Upadhya, MA | 1 |
| Umekar, MJ | 3 |
| Taksande, BG | 3 |
| Kotagale, NR | 3 |
| Wiśniewska, A | 1 |
| Olszanecki, R | 1 |
| Totoń-Żurańska, J | 1 |
| Kuś, K | 1 |
| Stachowicz, A | 1 |
| Suski, M | 1 |
| Gębska, A | 1 |
| Gajda, M | 1 |
| Jawień, J | 1 |
| Korbut, R | 1 |
| Gilad, GM | 1 |
| Gilad, VH | 1 |
| Faldu, DS | 1 |
| Sakaria, JN | 1 |
| Aglawe, MM | 1 |
| El-Awady, MS | 1 |
| Suddek, GM | 1 |
| Yarmohmmadi, F | 1 |
| Rahimi, N | 1 |
| Faghir-Ghanesefat, H | 1 |
| Javadian, N | 1 |
| Abdollahi, A | 1 |
| Pasalar, P | 1 |
| Jazayeri, F | 1 |
| Ejtemaeemehr, S | 1 |
| Dehpour, AR | 1 |
| Gawande, DY | 1 |
| Chopde, CT | 1 |
| Cui, H | 1 |
| Lee, JH | 1 |
| Kim, JY | 1 |
| Koo, BN | 1 |
| Lee, JE | 1 |
| Ozyazgan, S | 1 |
| Bicakci, B | 1 |
| Ozaydin, A | 1 |
| Denizbasi, A | 1 |
| Unluer, EE | 1 |
| Akkan, AG | 1 |
| Lewis, B | 1 |
| Wellmann, KA | 1 |
| Barron, S | 1 |
| Marx, M | 1 |
| Trittenwein, G | 1 |
| Aufricht, C | 1 |
| Hoeger, H | 1 |
| Lubec, B | 1 |
| Morgan, AD | 1 |
| Campbell, UC | 1 |
| Fons, RD | 1 |
| Carroll, ME | 1 |
12 other studies available for agmatine and Body Weight
| Article | Year |
|---|---|
Chronic agmatine treatment prevents olanzapine-induced obesity and metabolic dysregulation in female rats.
Topics: Agmatine; Animals; Antipsychotic Agents; Benzodiazepines; Body Weight; Eating; Female; Obesity; Olan | 2022 |
Anti-Atherosclerotic Action of Agmatine in ApoE-Knockout Mice.
Topics: Agmatine; Animals; Aorta; Apolipoproteins E; Atherosclerosis; Body Weight; Electrophoresis, Gel, Two | 2017 |
Evidence for oral agmatine sulfate safety--a 95-day high dosage pilot study with rats.
Topics: Administration, Oral; Agmatine; Animals; Behavior, Animal; Blood Pressure; Body Weight; Dose-Respons | 2013 |
Agmatine attenuates chronic unpredictable mild stress induced behavioral alteration in mice.
Topics: Agmatine; Animals; Antidepressive Agents; Behavior, Animal; Body Weight; Corticosterone; Depression; | 2013 |
Agmatine ameliorates atherosclerosis progression and endothelial dysfunction in high cholesterol-fed rabbits.
Topics: Agmatine; Animals; Atherosclerosis; Body Weight; Cholesterol; Disease Progression; Endothelium, Vasc | 2014 |
Protective effects of agmatine on doxorubicin-induced chronic cardiotoxicity in rat.
Topics: Agmatine; Animals; Antioxidants; Body Weight; Cardiotoxicity; Cytoprotection; Doxorubicin; Electroca | 2017 |
Agmatine ameliorates adjuvant induced arthritis and inflammatory cachexia in rats.
Topics: Agmatine; Animals; Arthritis, Experimental; Body Weight; Cachexia; Inflammation; Male; Rats; Rats, S | 2017 |
The neuroprotective effect of agmatine after focal cerebral ischemia in diabetic rats.
Topics: Agmatine; Animals; Apoptosis; Blood Glucose; Blotting, Western; Body Weight; Brain Edema; Cerebrovas | 2012 |
The effect of agmatine on the vascular reactivity in streptozotocin-diabetic rats.
Topics: Acetylcholine; Agmatine; Analysis of Variance; Animals; Aorta; Blood Glucose; Body Weight; Diabetes | 2003 |
Agmatine reduces balance deficits in a rat model of third trimester binge-like ethanol exposure.
Topics: Agmatine; Alcoholism; Animals; Animals, Newborn; Area Under Curve; Body Weight; Central Nervous Syst | 2007 |
Agmatine and spermidine reduce collagen accumulation in kidneys of diabetic db/db mice.
Topics: Agmatine; Animals; Blood Glucose; Body Weight; Collagen; Diabetes Mellitus, Experimental; Guanidines | 1995 |
Effects of agmatine on the escalation of intravenous cocaine and fentanyl self-administration in rats.
Topics: Agmatine; Analgesics, Opioid; Animals; Body Weight; Cocaine-Related Disorders; Conditioning, Operant | 2002 |